Pharma Logistics: Up in the Air or in Deep Water?
Tens of billions of dollars’ worth of (bio)pharmaceuticals are scrapped every year because of logistical hitches. What can be done to improve the situation? And which mode of transport – air or sea – should companies choose?
James Strachan |
What could be simpler than moving products from point A to point B? A great deal, as it turns out – especially when your product is a sensitive chemical compound or biological.
Shippers from all sectors have to deal with warehousing, transportation, customs clearance and regulatory compliance as they transport their goods across the world (easier said than done). But pharma companies also have to maintain a strict cold chain, where temperature excursions can ruin millions of dollars’ worth of drug – not to mention the potential impact on patients.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine